Diterpenoids with an unusual tricyclo[10.3.0.02,9]pentadecane skeleton from Pedilanthus tithymaloides as multidrug resistance modulators

Bioorg Chem. 2023 Sep:138:106619. doi: 10.1016/j.bioorg.2023.106619. Epub 2023 May 20.

Abstract

Three new diterpenoids with an unusual carbon skeleton, pedilanins A-C (1-3), and nine new jatrophane diterpenoids, pedilanins D-L (4-12), along with five known ones (13-17), were isolated from Pedilanthus tithymaloides. Compounds 1-3 characterize an unprecedented tricyclo[10.3.0.02,9]pentadecane skeleton. Compounds 4-8 are rare examples of the jatrophanes bearing a cyclic hemiketal substructure. Their structures were determined by an extensive analysis of HRESIMS, NMR, quantum-chemical calculation, DP4+ probability, and X-ray crystallographic data. In the bioassay, compounds 1-12 dramatically reversed multidrug resistance in cancer cells with the fold-reversals ranging from 17.9 to 396.8 at the noncytotoxic concentration of 10 μM. The mechanism results indicated that compounds 2 and 3 inhibited the P-glycoprotein (Pgp) transporter function, thus reversing the drug resistance.

Keywords: Diterpenoids; Jatrophanes; Multidrug resistance modulators; Pedilanins A-L; Pedilanthus tithymaloides.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Diterpenes* / chemistry
  • Diterpenes* / pharmacology
  • Drug Resistance, Multiple
  • Euphorbia* / chemistry
  • Molecular Structure
  • Radiopharmaceuticals / pharmacology

Substances

  • pentadecane
  • Radiopharmaceuticals
  • Diterpenes